Tag Archive | "option"

Aveo and Ophthotech in tivozanib pact

Tags: , ,


AVEO Oncology has entered into a research and exclusive option agreement with Ophthotech Read the full story

Evaluation

Tags: , , ,


Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to... Read the full story

Option

Tags: , ,


The term option within an deal refers to an integral part of an agreement already entered by the parties... Read the full story

Option and evaluation: recent partnering industry trends

Tags: , , ,


The article here analyses the recent partnering industry trends in the option and evaluation deal type areas. There are two major forms of deal terms that allow a party to secure rights to an asset subject to a future event Read the full story

Global Green, Inc. Signs Agreement with Merial for Evaluation of Salmonella Vaccine and License Option

Tags: , , ,


Global Green announces the signing of an agreement with Merial to conduct an internal evaluation of Global Green’s patented Salmogenics vaccine technology.

Read the full story

Celgene co-promotion, collaborative R&D and option agreement with FORMA for protein homeostasis targets regulation drug

Tags: , , ,


FORMA Therapeutics announced a strategic collaboration, co-promotion and option agreement with Celgene Corporation under which FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Read the full story

Merck in pharma licensing and option deal with Xenon

Tags: , , , ,


Big pharma company, Merck, in pharma licensing deal with Xenon stemming from a previous option agreement. Read the full story

Cubist Pharma explores biotech partnering with Adynxx

Tags: , , ,


Cubist Pharmaceuticals, a big biotech company, and Adynxx have entered into an option agreement under which Cubist explores biotech partnering with Adynxx. Read the full story

Biogen Idec and MAKScientific team up on MS drug candidates

Tags: , , ,


MAKScientific announced that it has entered into an exclusive option and collaboration agreement with Biogen Idec to develop and commercialize drug candidates for the treatment of multiple sclerosis and other neurodegenerative diseases. Read the full story

Merck establishes joint venture with Supera Farma to commercialize innovative pharma products and branded generics in Brazil

Tags: , , , ,


Merck announced the formation of a new joint venture with Supera Farma Laboratorios S.A., a Brazilian pharmaceutical company co-owned by Cristália and Eurofarma. Read the full story